Clinical Trials Logo

Hepatic Neoplasm Malignant clinical trials

View clinical trials related to Hepatic Neoplasm Malignant.

Filter by:
  • None
  • Page 1

NCT ID: NCT01245582 Withdrawn - Clinical trials for Hepatic Neoplasm Malignant

Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients

SECOX
Start date: July 2011
Phase: Phase 3
Study type: Interventional

Primary Objective: - To evaluate the efficacy of SECOX regimen by adding oxaliplatin plus capecitabine to sorafenib versus sorafenib alone as palliative treatment for unresectable HCC patients to prolong overall survival (OS) for advanced HCC patients. Secondary Objective: - To compare the efficacy of SECOX regimen with Sorafenib alone for progression free survival (PFS) - To compare the efficacy of SECOX regimen with Sorafenib alone for response rate (RR) - To assess the overall safety profile of SECOX regimen in comparison of Sorafenib alone